Finerenone is the first mineralocorticoid receptor (MR) antagonist to demonstrate definitive cardiovascular benefits in a Phase III study in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of ?40%
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
This two-day program was attended by 40 doctors & paramedical staff
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
The campaign targets 63 endemic districts across Bihar, Jharkhand, Karnataka, Odisha, Telangana, and Uttar Pradesh
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
Subscribe To Our Newsletter & Stay Updated
